Federal officials on Friday reversed Trump administration restrictions on using human fetal tissue for medical research.
The changes clear the way for using government money on work that in the past has led to treatments for a variety of diseases, including COVID-19.
Government scientists now will be able to resume research that uses tissue from elective abortions. Scientists at universities also can now apply for federal grants without getting approval from a special ethics panel for any such work.
Health and Human Services Secretary Xavier Becerra determined there were “no new ethical issues that require special review,” so the agency will return to using procedures that had been in place for decades before the Trump policy change in June 2019, a statement from the agency said.
Those include following applicable laws, such as obtaining informed consent from anyone donating such tissue. The changes were detailed in a notice to researchers.
Two dozen members of Congress who had written to Becerra urging the change praised the move. The restrictions were “politically motivated and unnecessary,” they wrote earlier this week.
The American Society of Reproductive Medicine also issued a statement applauding the change. “The United States government has developed a robust system of oversight. …. Ideologically driven politicians must not be allowed to interfere with this system on a whim,” the group said.
Research using fetal tissue led to vaccines for rubella and rabies and drugs to treat HIV. But such work has long been targeted by anti-abortion opponents.
Coronavirus: US states urge end to ban on fetal research
© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Federal officials reverse limits on fetal tissue research (2021, April 16)
retrieved 16 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Life expectancy in India dropped by two years due to COVID-19: Study - October 23, 2021
- US’ work with India on vaccine manufacturing saving people’s lives, says DFC chief - October 23, 2021
- Bengal reports steady Covid surge for third consecutive day - October 23, 2021
- Sri Lanka gives booster shots to front-line workers - October 23, 2021
- 3 children die of dengue in Uttar Pradesh - October 23, 2021
- India is close to turning the pandemic tide: Poonawalla - October 21, 2021
- Covishield may offer over 90% protection against death from Delta variant: Study - October 21, 2021
- PM Modi congratulated health workers on vaccinating 100 crore India’s population - October 21, 2021
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021